Therapeutic potential of curcumin in ARDS and COVID‐19

Suresh et al., Clinical and Experimental Pharmacology and Physiology, doi:10.1111/1440-1681.13744, Jan 2023

Curcumin for COVID-19

16th treatment shown to reduce risk in February 2021, now with p = 0.0000000061 from 28 studies.

No treatment is 100% effective.
Protocols combine treatments.

Review of the therapeutic potential of curcumin, specifically cyclodextrin-complexed curcumin (CDC), for treating ARDS and COVID-19.
Reviews covering curcumin for COVID-19 include1-16.
Suresh et al., 10 Jan 2023, peer-reviewed, 5 authors. Contact: madathil@umich.edu.
Abstract: DOI: 10.1111/1440-1681.13744 REVIEW Therapeutic potential of curcumin in ARDS and COVID-19 Madathilparambil V. Suresh | Sairah Francis | Sinan Aktay | Georgia Kralovich | Krishnan Raghavendran Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA Correspondence Suresh Madathilparambil, Department of Surgery, University of Michigan, 1500 E Medical Center Drive, Ann Arbor, Michigan, 48109, USA. Email: madathil@umich.edu Funding information National Institutes of Health, Grant/Award Number: HL102013 1 | I NTRODUCTION Curcumin is a yellow compound produced by plants of the Curcuma longa (turmeric) species. 1 It is the principal curcuminoid of Curcuma longa , a member of the ginger family, Zingiberaceae. 2,3 It is sold as an herbal supplement, cosmetic ingredient, food flavouring and colouring. It has various medicinal preparations common in Ayurveda and Chinese medicine. The medicinal properties of curcumin have been known for thousands of years; however, the exact mechanism(s) of action and bioactive components, many of which have yet to be determined, have only recently been investigated. 2 -4 Curcuminoids have been approved by the United States Food and Drug Administration (FDA) 2 and good tolerability and safety profiles have been shown by clinical trials. 3,5 According to the National Center for Complementary and Integrative Health, turmeric is generally safe, but consuming it in high doses or for extended periods may upset your stomach. Sairah Francis and Sinan Aktay contributed equally to this article. Abstract Curcumin is a safe, non-toxic, readily available and naturally occurring compound, an active constituent of Curcuma longa (turmeric). Curcumin could potentially treat diseases, but faces poor physicochemical and pharmacological characteristics. To overcome these limitations, we developed a stable, water-soluble formulation of curcumin called cyclodextrin-complexed curcumin (CDC). We have previously shown that direct delivery of CDC to the lung following lipopolysaccharides exposure reduces acute lung injury (ALI) and effectively reduces lung injury, inflammation and mortality in mice following Klebsiella pneumoniae . Recently, we found that administration of CDC led to a significant reduction in angiotensin-converting enzyme 2 and signal transducer and activator of transcription 3 expression in gene and protein levels following pneumonia, indicating its potential in treating coronavirus disease 2019 (COVID-19). In this review, we consider the clinical features of ALI and acute respiratory distress syndrome (ARDS) and the role of curcumin in modulating the pathogenesis of bacterial/viral-induced ARDS and COVID-19. KEYWORDS ALI, ARDS, COVID-19, curcumin, NFκ B, pneumonia Gupta et al 2 reported the safety of curcumin at doses as high as 12 g/day over 3 months in humans. Curcumin, a polyphenol, has been shown to target multiple signalling molecules while also demonstrating activity at the cellular level, which is most likely implicated in its numerous health benefits. 2,3,6 It has been shown to aid in metabolic syndromes, 7 pain 8 and inflammatory conditions. 9,10 The diverse effects of curcumin result from its action on a wide range of cellular targets, including transcription factors, inflammatory cytokines, growth factors, apoptotic proteins and more. 11,12 With so many varied biological targets, curcumin elicits numerous pleiotropic effects, and this renders it therapeutically advantageous because..
DOI record: { "DOI": "10.1111/1440-1681.13744", "ISSN": [ "0305-1870", "1440-1681" ], "URL": "http://dx.doi.org/10.1111/1440-1681.13744", "abstract": "<jats:title>Abstract</jats:title><jats:p>Curcumin is a safe, non‐toxic, readily available and naturally occurring compound, an active constituent of <jats:italic>Curcuma longa</jats:italic> (turmeric). Curcumin could potentially treat diseases, but faces poor physicochemical and pharmacological characteristics. To overcome these limitations, we developed a stable, water‐soluble formulation of curcumin called cyclodextrin‐complexed curcumin (CDC). We have previously shown that direct delivery of CDC to the lung following lipopolysaccharides exposure reduces acute lung injury (ALI) and effectively reduces lung injury, inflammation and mortality in mice following <jats:italic>Klebsiella pneumoniae</jats:italic>. Recently, we found that administration of CDC led to a significant reduction in angiotensin‐converting enzyme 2 and signal transducer and activator of transcription 3 expression in gene and protein levels following pneumonia, indicating its potential in treating coronavirus disease 2019 (COVID‐19). In this review, we consider the clinical features of ALI and acute respiratory distress syndrome (ARDS) and the role of curcumin in modulating the pathogenesis of bacterial/viral‐induced ARDS and COVID‐19.</jats:p>", "alternative-id": [ "10.1111/1440-1681.13744" ], "assertion": [ { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Received", "name": "received", "order": 0, "value": "2022-08-10" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Accepted", "name": "accepted", "order": 1, "value": "2022-11-30" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Published", "name": "published", "order": 2, "value": "2023-01-10" } ], "author": [ { "affiliation": [ { "name": "Department of Surgery University of Michigan Ann Arbor Michigan USA" } ], "family": "Suresh", "given": "Madathilparambil V.", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "first" }, { "affiliation": [ { "name": "Department of Surgery University of Michigan Ann Arbor Michigan USA" } ], "family": "Francis", "given": "Sairah", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Department of Surgery University of Michigan Ann Arbor Michigan USA" } ], "family": "Aktay", "given": "Sinan", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Department of Surgery University of Michigan Ann Arbor Michigan USA" } ], "family": "Kralovich", "given": "Georgia", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "Department of Surgery University of Michigan Ann Arbor Michigan USA" } ], "family": "Raghavendran", "given": "Krishnan", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" } ], "container-title": "Clinical and Experimental Pharmacology and Physiology", "container-title-short": "Clin Exp Pharma Physio", "content-domain": { "crossmark-restriction": true, "domain": [ "onlinelibrary.wiley.com" ] }, "created": { "date-parts": [ [ 2022, 12, 8 ] ], "date-time": "2022-12-08T16:11:12Z", "timestamp": 1670515872000 }, "deposited": { "date-parts": [ [ 2023, 8, 18 ] ], "date-time": "2023-08-18T20:08:35Z", "timestamp": 1692389315000 }, "funder": [ { "DOI": "10.13039/100000002", "award": [ "HL102013" ], "award-info": [ { "award-number": [ "HL102013" ] } ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100000002", "id-type": "DOI" } ], "name": "National Institutes of Health" } ], "indexed": { "date-parts": [ [ 2026, 9, 9 ] ], "date-time": "2026-09-09T23:04:26Z", "timestamp": 1788995066048, "version": "build-2803163510" }, "is-referenced-by-count": 20, "issue": "4", "issued": { "date-parts": [ [ 2023, 1, 10 ] ] }, "journal-issue": { "issue": "4", "published-print": { "date-parts": [ [ 2023, 4 ] ] } }, "language": "en", "license": [ { "URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 1, 10 ] ], "date-time": "2023-01-10T00:00:00Z", "timestamp": 1673308800000 } } ], "link": [ { "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13744", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1111/1440-1681.13744", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13744", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "311", "original-title": [], "page": "267-276", "prefix": "10.1111", "published": { "date-parts": [ [ 2023, 1, 10 ] ] }, "published-online": { "date-parts": [ [ 2023, 1, 10 ] ] }, "published-print": { "date-parts": [ [ 2023, 4 ] ] }, "publisher": "Wiley", "reference": [ { "DOI": "10.1016/S0378-5173(02)00323-X", "doi-asserted-by": "publisher", "key": "e_1_2_14_2_1" }, { "DOI": "10.1208/s12248-012-9432-8", "doi-asserted-by": "publisher", "key": "e_1_2_14_3_1" }, { "DOI": "10.3390/foods6100092", "doi-asserted-by": "publisher", "key": "e_1_2_14_4_1" }, { "DOI": "10.3389/fphar.2020.01021", "doi-asserted-by": "publisher", "key": "e_1_2_14_5_1" }, { "DOI": "10.1186/1472-6882-6-10", "doi-asserted-by": "publisher", "key": "e_1_2_14_6_1" }, { "DOI": "10.1016/j.biocel.2008.06.010", "doi-asserted-by": "publisher", "key": "e_1_2_14_7_1" }, { "DOI": "10.1016/j.biopha.2016.05.037", "doi-asserted-by": "publisher", "key": "e_1_2_14_8_1" }, { "DOI": "10.2147/CIA.S58535", "doi-asserted-by": "publisher", "key": "e_1_2_14_9_1" }, { "article-title": "Dimensional stability of impression materials immersed in an iodophor disinfectant", "author": "Giblin J", "first-page": "72", "issue": "1", "journal-title": "Int J Prosthodont", "key": "e_1_2_14_10_1", "volume": "3", "year": "1990" }, { "DOI": "10.3390/molecules16064567", "doi-asserted-by": "publisher", "key": "e_1_2_14_11_1" }, { "DOI": "10.1186/1471-2407-11-112", "doi-asserted-by": "publisher", "key": "e_1_2_14_12_1" }, { "DOI": "10.1055/s-2006-957450", "doi-asserted-by": "publisher", "key": "e_1_2_14_13_1" }, { "DOI": "10.2174/1381612824666180522111036", "doi-asserted-by": "publisher", "key": "e_1_2_14_14_1" }, { "DOI": "10.1016/j.jtcme.2016.05.005", "doi-asserted-by": "publisher", "key": "e_1_2_14_15_1" }, { "DOI": "10.1007/s10875-006-9066-7", "doi-asserted-by": "publisher", "key": "e_1_2_14_16_1" }, { "article-title": "Curcumin attenuates the expression of IL‐1beta, IL‐6, and TNF‐alpha as well as cyclin E in TNF‐alpha‐treated HaCaT cells; NF‐kappaB and MAPKs as potential upstream targets", "author": "Cho JW", "first-page": "469", "issue": "3", "journal-title": "Int J Mol Med", "key": "e_1_2_14_17_1", "volume": "19", "year": "2007" }, { "DOI": "10.1165/rcmb.2011-0175OC", "doi-asserted-by": "publisher", "key": "e_1_2_14_18_1" }, { "DOI": "10.1186/1747-1028-3-14", "doi-asserted-by": "publisher", "key": "e_1_2_14_19_1" }, { "DOI": "10.1172/JCI137244", "doi-asserted-by": "publisher", "key": "e_1_2_14_20_1" }, { "DOI": "10.1155/2014/394264", "doi-asserted-by": "publisher", "key": "e_1_2_14_21_1" }, { "article-title": "Inhalable Mannosylated rifampicin‐curcumin Co‐loaded Nanomicelles with enhanced In vitro antimicrobial efficacy for an optimized pulmonary tuberculosis therapy", "author": "Galdoporpora JM", "journal-title": "Pharmaceutics", "key": "e_1_2_14_22_1", "volume": "299", "year": "2010" }, { "DOI": "10.1002/jcp.30233", "doi-asserted-by": "publisher", "key": "e_1_2_14_23_1" }, { "DOI": "10.1002/bdd.2108", "doi-asserted-by": "publisher", "key": "e_1_2_14_24_1" }, { "DOI": "10.1096/fj.201901047RR", "doi-asserted-by": "publisher", "key": "e_1_2_14_25_1" }, { "DOI": "10.1096/fj.03-0329fje", "doi-asserted-by": "publisher", "key": "e_1_2_14_26_1" }, { "article-title": "NF‐kappaB signaling in inflammation", "author": "Liu T", "first-page": "2:17023", "journal-title": "Signal Transduct Target Ther", "key": "e_1_2_14_27_1", "year": "2017" }, { "DOI": "10.3389/fcell.2021.751761", "doi-asserted-by": "publisher", "key": "e_1_2_14_28_1" }, { "DOI": "10.3389/fcell.2020.00479", "doi-asserted-by": "publisher", "key": "e_1_2_14_29_1" }, { "DOI": "10.3390/molecules19068289", "doi-asserted-by": "publisher", "key": "e_1_2_14_30_1" }, { "DOI": "10.1084/jem.20171419", "doi-asserted-by": "publisher", "key": "e_1_2_14_31_1" }, { "DOI": "10.1100/2011/212680", "doi-asserted-by": "publisher", "key": "e_1_2_14_32_1" }, { "DOI": "10.1080/10715762.2021.2023740", "doi-asserted-by": "publisher", "key": "e_1_2_14_33_1" }, { "DOI": "10.1016/j.bbadis.2016.11.005", "doi-asserted-by": "publisher", "key": "e_1_2_14_34_1" }, { "DOI": "10.1111/bcpt.13503", "doi-asserted-by": "publisher", "key": "e_1_2_14_35_1" }, { "DOI": "10.1002/jcb.27969", "doi-asserted-by": "publisher", "key": "e_1_2_14_36_1" }, { "DOI": "10.3389/fimmu.2020.00211", "doi-asserted-by": "publisher", "key": "e_1_2_14_37_1" }, { "DOI": "10.1186/s13075-019-1974-z", "doi-asserted-by": "publisher", "key": "e_1_2_14_38_1" }, { "DOI": "10.1111/j.1365-2567.2005.02091.x", "doi-asserted-by": "publisher", "key": "e_1_2_14_39_1" }, { "DOI": "10.1016/j.micpath.2021.104836", "doi-asserted-by": "publisher", "key": "e_1_2_14_40_1" }, { "DOI": "10.1152/ajpgi.00065.2010", "doi-asserted-by": "publisher", "key": "e_1_2_14_41_1" }, { "DOI": "10.1165/rcmb.2004-0314OC", "doi-asserted-by": "publisher", "key": "e_1_2_14_42_1" }, { "DOI": "10.1074/jbc.271.50.32253", "doi-asserted-by": "publisher", "key": "e_1_2_14_43_1" }, { "DOI": "10.1038/aps.2012.5", "doi-asserted-by": "publisher", "key": "e_1_2_14_44_1" }, { "DOI": "10.1016/j.phrs.2018.10.009", "doi-asserted-by": "publisher", "key": "e_1_2_14_45_1" }, { "article-title": "Curcumin inhibits hypoxia‐induced angiogenesis via down‐regulation of HIF‐1", "author": "Bae MK", "first-page": "1557", "issue": "6", "journal-title": "Oncol Rep", "key": "e_1_2_14_46_1", "volume": "15", "year": "2006" }, { "DOI": "10.4049/jimmunol.1202410", "doi-asserted-by": "publisher", "key": "e_1_2_14_47_1" }, { "DOI": "10.2174/1566524019666191016150757", "doi-asserted-by": "publisher", "key": "e_1_2_14_48_1" }, { "DOI": "10.5271/sjweh.3960", "doi-asserted-by": "publisher", "key": "e_1_2_14_49_1" }, { "article-title": "Coronavirus management and control: nutrition and alternative medicines", "author": "Guha S", "journal-title": "Nutr Health", "key": "e_1_2_14_50_1" }, { "DOI": "10.1038/s41421-020-0168-9", "doi-asserted-by": "publisher", "key": "e_1_2_14_51_1" }, { "DOI": "10.1002/oby.22831", "doi-asserted-by": "publisher", "key": "e_1_2_14_52_1" }, { "DOI": "10.1016/j.ajem.2007.06.032", "doi-asserted-by": "publisher", "key": "e_1_2_14_53_1" }, { "DOI": "10.1001/jama.2020.2648", "doi-asserted-by": "publisher", "key": "e_1_2_14_54_1" }, { "DOI": "10.3389/fphar.2021.669362", "doi-asserted-by": "publisher", "key": "e_1_2_14_55_1" }, { "DOI": "10.3389/fphar.2021.675287", "doi-asserted-by": "publisher", "key": "e_1_2_14_56_1" }, { "DOI": "10.1016/j.virol.2011.02.020", "doi-asserted-by": "publisher", "key": "e_1_2_14_57_1" }, { "DOI": "10.1186/s13054-020-03120-0", "doi-asserted-by": "publisher", "key": "e_1_2_14_58_1" }, { "DOI": "10.1016/j.intimp.2020.107088", "doi-asserted-by": "publisher", "key": "e_1_2_14_59_1" }, { "article-title": "Enhanced curcumin loaded nanocellulose: a possible inhalable nanotherapeutic to treat COVID‐19", "author": "Gunathilake TMSU", "journal-title": "Cellulose (Lond)", "key": "e_1_2_14_60_1", "volume": "29", "year": "2022" }, { "DOI": "10.1007/s10570-021-04391-8", "doi-asserted-by": "publisher", "key": "e_1_2_14_61_1" }, { "DOI": "10.1111/j.1600-0609.2009.01238.x", "doi-asserted-by": "publisher", "key": "e_1_2_14_62_1" }, { "DOI": "10.3892/etm.2021.9916", "doi-asserted-by": "publisher", "key": "e_1_2_14_63_1" }, { "DOI": "10.1016/j.ijbiomac.2021.12.073", "doi-asserted-by": "publisher", "key": "e_1_2_14_64_1" }, { "DOI": "10.1016/j.ijbiomac.2021.12.073", "doi-asserted-by": "publisher", "key": "e_1_2_14_65_1" }, { "DOI": "10.3390/molecules26226900", "doi-asserted-by": "publisher", "key": "e_1_2_14_66_1" }, { "DOI": "10.1016/j.heliyon.2021.e06350", "doi-asserted-by": "publisher", "key": "e_1_2_14_67_1" }, { "DOI": "10.1002/fsn3.1858", "doi-asserted-by": "publisher", "key": "e_1_2_14_68_1" }, { "DOI": "10.3390/nu14020256", "doi-asserted-by": "publisher", "key": "e_1_2_14_69_1" }, { "DOI": "10.1186/s13063-022-06375-w", "doi-asserted-by": "publisher", "key": "e_1_2_14_70_1" }, { "DOI": "10.1055/a-1275-0228", "doi-asserted-by": "publisher", "key": "e_1_2_14_71_1" }, { "DOI": "10.1016/j.compbiomed.2022.105552", "doi-asserted-by": "publisher", "key": "e_1_2_14_72_1" }, { "DOI": "10.1080/08923973.2022.2037631", "doi-asserted-by": "publisher", "key": "e_1_2_14_73_1" }, { "DOI": "10.1002/ptr.7004", "doi-asserted-by": "publisher", "key": "e_1_2_14_74_1" }, { "article-title": "Role of nuclear factor erythroid 2 (Nrf2) in the recovery of long COVID‐19 using natural antioxidants: a systematic review", "author": "Muchtaridi M", "issue": "8", "journal-title": "Antioxidants (Basel)", "key": "e_1_2_14_75_1", "volume": "11", "year": "2022" }, { "DOI": "10.2174/1381612827666210114150607", "doi-asserted-by": "publisher", "key": "e_1_2_14_76_1" }, { "DOI": "10.1002/path.1570", "doi-asserted-by": "publisher", "key": "e_1_2_14_77_1" }, { "DOI": "10.1038/s41598-022-07918-6", "doi-asserted-by": "publisher", "key": "e_1_2_14_78_1" }, { "DOI": "10.1039/D0RA03167D", "doi-asserted-by": "publisher", "key": "e_1_2_14_79_1" }, { "article-title": "Severe acute respiratory syndrome Coronavirus‐2 (SARS‐CoV‐2): an update", "author": "Pal M", "first-page": "e7423", "issue": "3", "journal-title": "Cureus", "key": "e_1_2_14_80_1", "volume": "12", "year": "2020" }, { "DOI": "10.1126/science.abb2507", "doi-asserted-by": "publisher", "key": "e_1_2_14_81_1" }, { "DOI": "10.1016/j.jff.2021.104503", "doi-asserted-by": "publisher", "key": "e_1_2_14_82_1" }, { "DOI": "10.1007/s00134-020-05985-9", "doi-asserted-by": "publisher", "key": "e_1_2_14_83_1" }, { "DOI": "10.1016/j.ccc.2011.05.006", "doi-asserted-by": "publisher", "key": "e_1_2_14_84_1" }, { "DOI": "10.1016/S0002-9440(10)64455-0", "doi-asserted-by": "publisher", "key": "e_1_2_14_85_1" }, { "DOI": "10.1007/s10753-021-01613-w", "doi-asserted-by": "publisher", "key": "e_1_2_14_86_1" }, { "article-title": "Static and dynamic pressure‐volume curves reflect different aspects of respiratory system mechanics in experimental acute respiratory distress syndrome", "author": "Adams AB", "first-page": "686", "issue": "7", "journal-title": "Respir Care", "key": "e_1_2_14_87_1", "volume": "46", "year": "2001" }, { "DOI": "10.1056/NEJM200005043421801", "doi-asserted-by": "publisher", "key": "e_1_2_14_88_1" }, { "DOI": "10.1186/cc11144", "doi-asserted-by": "publisher", "key": "e_1_2_14_89_1" }, { "article-title": "Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung", "author": "Uhal BD", "first-page": "L1192", "issue": "6", "journal-title": "Am J Physiol", "key": "e_1_2_14_90_1", "volume": "275", "year": "1998" }, { "DOI": "10.1378/chest.121.6.1972", "doi-asserted-by": "publisher", "key": "e_1_2_14_91_1" }, { "DOI": "10.1056/NEJM198712173172504", "doi-asserted-by": "publisher", "key": "e_1_2_14_92_1" }, { "DOI": "10.1186/s12931-015-0199-1", "doi-asserted-by": "publisher", "key": "e_1_2_14_93_1" }, { "article-title": "Protective effect of curcumin on oleic‐induced acute lung injury in rats", "author": "Zhu RF", "first-page": "2141", "issue": "17", "journal-title": "Zhongguo Zhong Yao Za Zhi", "key": "e_1_2_14_94_1", "volume": "33", "year": "2008" }, { "DOI": "10.1097/ACO.0b013e3282f5335c", "doi-asserted-by": "publisher", "key": "e_1_2_14_95_1" }, { "DOI": "10.1189/jlb.0503214", "doi-asserted-by": "publisher", "key": "e_1_2_14_96_1" }, { "DOI": "10.1007/s00383-008-2282-x", "doi-asserted-by": "publisher", "key": "e_1_2_14_97_1" }, { "DOI": "10.1002/jcb.26384", "doi-asserted-by": "publisher", "key": "e_1_2_14_98_1" }, { "DOI": "10.1016/S0140-6736(05)64630-2", "doi-asserted-by": "publisher", "key": "e_1_2_14_99_1" }, { "DOI": "10.2174/187153008786848321", "doi-asserted-by": "publisher", "key": "e_1_2_14_100_1" }, { "DOI": "10.1053/srin.2000.20938", "doi-asserted-by": "publisher", "key": "e_1_2_14_101_1" }, { "article-title": "Chronic Klebsiella pneumonia: a rare manifestation of Klebsiella pneumonia", "author": "Boonsarngsuk V", "first-page": "1661", "issue": "9", "journal-title": "J Thorac Dis", "key": "e_1_2_14_102_1", "volume": "7", "year": "2015" }, { "DOI": "10.4049/jimmunol.1200585", "doi-asserted-by": "publisher", "key": "e_1_2_14_103_1" }, { "article-title": "Possible role of curcumin as an efflux pump inhibitor in multi drug resistant clinical isolates of Pseudomonas aeruginosa", "author": "Negi N", "first-page": "DC04", "issue": "10", "journal-title": "J Clin Diagn Res", "key": "e_1_2_14_104_1", "volume": "8", "year": "2014" }, { "DOI": "10.3390/molecules191118283", "doi-asserted-by": "publisher", "key": "e_1_2_14_105_1" }, { "DOI": "10.3934/microbiol.2019.2.117", "doi-asserted-by": "publisher", "key": "e_1_2_14_106_1" }, { "DOI": "10.1186/s13756-019-0559-6", "doi-asserted-by": "publisher", "key": "e_1_2_14_107_1" }, { "DOI": "10.4103/0976-0105.183265", "doi-asserted-by": "publisher", "key": "e_1_2_14_108_1" }, { "DOI": "10.1177/0748233713498458", "doi-asserted-by": "publisher", "key": "e_1_2_14_109_1" }, { "DOI": "10.1002/ptr.6939", "doi-asserted-by": "publisher", "key": "e_1_2_14_110_1" } ], "reference-count": 109, "references-count": 109, "relation": {}, "resource": { "primary": { "URL": "https://onlinelibrary.wiley.com/doi/10.1111/1440-1681.13744" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Therapeutic potential of curcumin in <scp>ARDS</scp> and <scp>COVID</scp>‐19", "type": "journal-article", "update-policy": "https://doi.org/10.1002/crossmark_policy", "volume": "50" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit